Micol Rothman, MD
Professor, Medicine-Endocrinology/Metabolism/Diabetes

Professional Titles

• Associate Professor of Medicine and Radiology

Recognition & Awards

• 5280 Top Doctors, 5280 Magazine (2017)
• RIsing Star, Department of Medicine (2014)
• University of Colorado , Adult Ambulatroy Care Clerkship (2010)
  For Outstanding Dedication to Student Teaching and Education

Research Interests

Publications

• Lewiecki EM, Anderson PA, Bilezikian JP, Binkley N, Cheung AM, Imel EA, Krueger D, McClung MR, Miller PD, Rothman MS. Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases. J Clin Densitom. 2022 Jan-Mar;25(1):3-19. PubMed PMID: 34785102
• Zaman A, Rothman MS, Billups SJ. Stop the denosumab delay! The effect of implementing an automatic reminder in the electronic medical record. Arch Osteoporos. 2022 Jan 20;17(1):18. PubMed PMID: 35050418
• Sotiros AR, Iwamoto SJ, Rothman MS, Lee RS. A Novel Multidisciplinary Model of Care for Transgender and Gender Diverse Adults: Program Description and Patient Perspectives. Transgend Health. 2022 Jun;7(3):276-281. PubMed PMID: 36643065
• McClung MR, Rothman MS, Lewiecki EM, Hanley DA, Harris ST, Miller PD, Kendler DL. The role of osteoanabolic agents in the management of patients with osteoporosis. Postgrad Med. 2022 Aug;134(6):541-551. PubMed PMID: 35635798
• Zaman A, Rothman MS, Billups SJ. Stop the denosumab delay! The effect of implementing an automatic reminder in the electronic medical record. Arch Osteoporos. 2022 Jan 20;17(1):18. PubMed PMID: 35050418
• Lewiecki EM, Anderson PA, Bilezikian JP, Binkley N, Cheung AM, Imel EA, Krueger D, McClung MR, Miller PD, Rothman MS. Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases. J Clin Densitom. 2022 Jan-Mar;25(1):3-19. PubMed PMID: 34785102
• Zaman A, Rothman MS. Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies. Endocrinol Metab Clin North Am. 2021 Mar;50(1):97-111. PubMed PMID: 33518189
• Iwamoto SJ, Grimstad F, Irwig MS, Rothman MS. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review. J Gen Intern Med. 2021 May;36(5):1380-1389. PubMed PMID: 33547576
• Sotiros A, Iwamoto SJ, Rothman MS, Lee R A Novel Model Multidisciplinary Model of Care for Transgender and Gender Diverse Adults: Program Description and Patient Perspectives Transgender Health 2021
• Lewiecki EM, Rothman MS. COVID-19, Medical Education, and Bone Health: Insights From Project ECHO. J Clin Densitom. 2020 Jul-Sep;23(3):338-339. PubMed PMID: 32448715
• Iwamoto SJ, Rothman MS, Duan S, Baker JC, Mumm S, Whyte MP. Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK. Bone. 2020 Apr;133:115224. PubMed PMID: 31923705
• Wallace MA, Hammes A, Rothman MS, Trizno AA, Jones CD, Cumbler E, McDevitt K, Carlson NE, Stoneback JW. Fixing a Fragmented System: Impact of a Comprehensive Geriatric Hip Fracture Program on Long-Term Mortality. Perm J. 2019;23. PubMed PMID: 31702983
• Iwamoto SJ, Defreyne J, Rothman MS, Van Schuylenbergh J, Van de Bruaene L, Motmans J, T'Sjoen G. Health considerations for transgender women and remaining unknowns: a narrative review. Ther Adv Endocrinol Metab. 2019;10:2042018819871166. PubMed PMID: 31516689
• Rothman MS, Olenginski TP, Stanciu I, Krohn K, Lewiecki EM. Lessons learned with Bone Health TeleECHO: making treatment decisions when guidelines conflict. Osteoporos Int. 2019 Dec;30(12):2401-2406. PubMed PMID: 31471665
• Rothman MS, Iwamoto SJ. Bone Health in the Transgender Population. Clin Rev Bone Miner Metab. 2019 Jun;17(2):77-85. PubMed PMID: 31452648
• Iwamoto SJ, T'Sjoen G, Safer JD, Davidge-Pitts CJ, Wierman ME, Glodowski MB, Rothman MS. Letter to the Editor: "Progesterone Is Important for Transgender Women's Therapy-Applying Evidence for the Benefits of Progesterone in Ciswomen". J Clin Endocrinol Metab. 2019 Aug 1;104(8):3127-3128. PubMed PMID: 30860591
• Schorr M, Drabkin A, Rothman MS, Meenaghan E, Lashen GT, Mascolo M, Watters A, Holmes TM, Santoso K, Yu EW, Misra M, Eddy KT, Klibanski A, Mehler P, Miller KK. Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder. Clin Endocrinol (Oxf). 2019 Jun;90(6):789-797. PubMed PMID: 30817009
• Drabkin A, Rothman MS, Wassenaar E, Mascolo M, Mehler PS. Assessment and clinical management of bone disease in adults with eating disorders: a review. J Eat Disord. 2017;5:42. PubMed PMID: 29214023
• Rothman MS, Lewiecki EM, Miller PD. Bone Density Testing Is the Best Way to Monitor Osteoporosis Treatment. Am J Med. 2017 Oct;130(10):1133-1134. PubMed PMID: 28687261
• Rothman MS, Miller PD, Lewiecki E, Bilezikian JP. Bone density testing: science, the media, and patient care. Curr Osteoporos Rep. 2014 Jun;12(2):227-9. PubMed PMID: 24659466
• Weickhardt AJ, Doebele RC, Purcell WT, Bunn PA, Oton AB, Rothman MS, Wierman ME, Mok T, Popat S, Bauman J, Nieva J, Novello S, Ou SH, Camidge DR. Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients. Cancer. 2013 Jul 1;119(13):2383-90. PubMed PMID: 23585220
• Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman MS, Nagabhushanam V, McDermott M, Levin AR, Frazer-Abel A, Giclas PC, Korner J, Iseman MD, Shapiro L, Chan ED. Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med. 2013 Jan 15;187(2):197-205. PubMed PMID: 23144328

Professional Memberships

• Endocrine Society, Member
• ASBMR, Member